Frontiers in Oncology | Cancer Genetics

Original Research

Published on 06 Apr 2023

Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer

in Cancer Genetics

Courtney J. Riedinger
Morgan Brown
Paulina J. Haight
Floor J. Backes
David E. Cohn
Paul J. Goodfellow
Casey M. Cosgrove

Frontiers in Oncology

doi 10.3389/fonc.2023.1147657

2,442 views
6 citations

Review

Published on 06 Apr 2023

Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia

in Cancer Genetics

Blaž Oder
Anastasia Chatzidimitriou
Anton W. Langerak
Richard Rosenquist
Cecilia Österholm

Frontiers in Oncology

doi 10.3389/fonc.2023.1143811

5,189 views
2 citations

Original Research

Published on 06 Apr 2023

Computational modeling of locoregional recurrence with spatial structure identifies tissue-specific carcinogenic profiles

in Cancer Genetics

Sharafudeen Dahiru Abubakar
Mitsuaki Takaki
Hiroshi Haeno

Frontiers in Oncology

doi 10.3389/fonc.2023.1116210

1,756 views
2 citations

Original Research

Published on 04 Apr 2023

Identification of p53-target genes in human papillomavirus-associated head and neck cancer by integrative bioinformatics analysis

in Cancer Genetics

Amal Bouzid
Muwaffaq Al Ani
David de la Fuente
Zainab Mohamed Al Shareef
Asif Quadri
Rifat Hamoudi
Natheer Al-Rawi

Frontiers in Oncology

doi 10.3389/fonc.2023.1128753

3,811 views
2 citations

Editorial

Published on 31 Mar 2023

Editorial: Artificial intelligence: A step forward in biomarker discovery and integration towards improved cancer diagnosis and treatment

in Cancer Genetics

Mónica Hebe Vazquez-Levin
Jaume Reventos
George Zaki

Frontiers in Oncology

doi 10.3389/fonc.2023.1161118

3,489 views
4 citations

Review

Published on 29 Mar 2023

Expression and molecular regulation of non-coding RNAs in HPV-positive head and neck squamous cell carcinoma

in Cancer Genetics

Dandan Guo
Mei Yang
Shiyun Li
Weiwei Zhu
Meixin Chen
Jiayu Pan
Dan Long
Zhaohui Liu
Chunlin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1122982

3,287 views
4 citations

Correction

Published on 28 Mar 2023

Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer

in Cancer Genetics

Gianluca Mauri
Giorgio Patelli
Viviana Gori
Calogero Lauricella
Benedetta Mussolin
Alessio Amatu
Katia Bencardino
Federica Tosi
Erica Bonazzina
Emanuela Bonoldi

Frontiers in Oncology

doi 10.3389/fonc.2023.1147497

1,107 views
2 citations

Editorial

Published on 28 Mar 2023

Editorial: Application and innovation of multiomics technologies in clinical oncology

in Cancer Genetics

Xinmin Li
Anton Budzin
Ye Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1179829

857 views
1 citation

Original Research

Published on 24 Mar 2023

Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population

in Cancer Genetics

Ning Ma
Ao Jin
Yitong Sun
Yiyao Jin
Yucheng Sun
Qian Xiao
XuanYi Sha
Fengxue Yu
Lei Yang
Wenxuan Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1124459

2,626 views
2 citations

Original Research

Published on 23 Mar 2023

Heterogeneous pattern of gene expression driven by TTN mutation is involved in the construction of a prognosis model of lung squamous cell carcinoma

in Cancer Genetics

Zhao Liu
Xiaowen Zhao
Ruihong Wang
Xiangyue Tang
Yuxiang Zhao
Guanghui Zhong
Xin Peng
Chunlin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.916568

1,796 views
2 citations

Original Research

Published on 23 Mar 2023

Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren’s syndrome patients through immunogenetics

in Cancer Genetics

P. Martijn Kolijn
Erika Huijser
M. Javad Wahadat
Cornelia G. van Helden-Meeuwsen
Paul L. A. van Daele
Zana Brkic
Jos Rijntjes
Konnie M. Hebeda
Patricia J. T. A. Groenen
Marjan A. Versnel

Frontiers in Oncology

doi 10.3389/fonc.2023.1130686

1,700 views
4 citations

Original Research

Published on 23 Mar 2023

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma

in Cancer Genetics

Jun-Song Zhang
Run-Sang Pan
Xiao-Bin Tian

Frontiers in Oncology

doi 10.3389/fonc.2023.1156663

2,482 views
1 citation

Editorial

Published on 22 Mar 2023

Editorial: The roles of genome and epigenome in poorly studied male-specific cancers

in Cancer Genetics

Rong Na
Qiyuan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1166320

799 views

Review

Published on 22 Mar 2023

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies

in Cancer Genetics

Shizuko Sei
Aysel Ahadova
Derin B. Keskin
Lena Bohaumilitzky
Johannes Gebert
Magnus von Knebel Doeberitz
Steven M. Lipkin
Matthias Kloor

Frontiers in Oncology

doi 10.3389/fonc.2023.1147590

9,121 views
14 citations

Case Report

Published on 21 Mar 2023

A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report

in Cancer Genetics

Mara Colombo
Patrizia Mondini
Elisa Minenza
Claudia Foglia
Annamaria Mosconi
Carmen Molica
Lorenza Pistola
Vienna Ludovini
Paolo Radice

Frontiers in Oncology

doi 10.3389/fonc.2023.1102184

2,291 views
1 citation

Review

Published on 17 Mar 2023

Epitranscriptomics in the development, functions, and disorders of cancer stem cells

in Cancer Genetics

Linlin Hao
Jian Zhang
Zhongshan Liu
Xia Lin
Jie Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1145766

2,545 views
2 citations

Navigation group

Articles

Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer

Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia

Computational modeling of locoregional recurrence with spatial structure identifies tissue-specific carcinogenic profiles

Identification of p53-target genes in human papillomavirus-associated head and neck cancer by integrative bioinformatics analysis

Editorial: Artificial intelligence: A step forward in biomarker discovery and integration towards improved cancer diagnosis and treatment

Expression and molecular regulation of non-coding RNAs in HPV-positive head and neck squamous cell carcinoma

Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer

Editorial: Application and innovation of multiomics technologies in clinical oncology

Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population

Heterogeneous pattern of gene expression driven by TTN mutation is involved in the construction of a prognosis model of lung squamous cell carcinoma

Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren’s syndrome patients through immunogenetics

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma

Editorial: The roles of genome and epigenome in poorly studied male-specific cancers

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies

A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report

Epitranscriptomics in the development, functions, and disorders of cancer stem cells